scan as pretreatmentassessment in patients who undergo salvage radiotherapy forrising prostate-specific antigen after radical prostatectomy forprostate cancer[j]. int j radiat oncol, 2007, 67(3): 834-840. [39] nakajima t, mitsuna...
分析柱Phenomenex Gemini 5 μm 100A C18(4.6 mm×150 mm),BioScan流动放射性检测器;内毒素快速检测仪(PTS)购自美国Charles river公司;γ计数仪购自芬兰Hidex公司;SPECT/CT(Discovery NM/CT 670 CZT)购自美国GE公司;离心机购自北...
图 Fig. 1 An example of a whole body [68Ga]Ga-PSMA PET scan acquired from the skull to the middle of the thigh. The left image (A) shows a coronal view without any segmentation, the middle image (B) shows manual segmentations, and the right image (C) shows automated segmentations....
[12]Daniele Robesti, et al. MP48-13 The Key Role Of Concomitant Androgen-Deprivation Therapy On The Efficacy Of Imaging Guided Treatments In Men With Biochemical Recurrent Prostate Cancer After Radical Prostatectomy And Positive 68Ga-Psma Pet/Ct Scan. Presented at: AUA 2022. The Journal of Uro...
[12]Daniele Robesti, et al. MP48-13 The Key Role Of Concomitant Androgen-Deprivation Therapy On The Efficacy Of Imaging Guided Treatments In Men With Biochemical Recurrent Prostate Cancer After Radical Prostatectomy And Positive 68Ga-Psma Pet/Ct Scan. Presented at: AUA 2022. The Journal of Uro...
使用靶向PSMA的放射性标记配体进行放射配体治疗(radioligand therapy,RLT)已成为诊断和治疗转移性去势抵抗性前列腺癌(metastatic castration-resistant prostate cancer,mCRPC)的一种有前景的策略[3],其具有精准、高效、不良反应小、诊疗一体化等优势。目前,最常用的靶向PSMA的RLT使用的放射性药物是177Lu-PSMA-617和177Lu...
选择性地结合于特异性肿瘤细胞表面蛋白的放射性分子提供了用于在非侵入性条件下成像和治疗肿瘤的有吸引力的途径。有前途的新系列的低分子量成像剂靶向前列腺特异性膜抗原(psma)(measer.c.etal.clincancerres.2008,14,3036-3043;foss,c.a.;etal.clincancerres2005,11,4022-4028;pomper,m.g.;etal.molimaging...
Methods: In the past year, 275 prostate cancer patients were scanned at our facility (INITIO Medical Imaging, Burnaby BC) through Health Canada SA. All patients were required to have positive prostate cancer biopsies, with negative or indeterminate CT and bone scan, and rising PSA (prostate ...
过去5年里,正电子放射断层造影术(PET)在前列腺癌一、二级分期中得到了广泛应用,加上前列腺特异性膜抗原(PSMA)在前列腺癌成像中是放射性示踪剂一个有吸引力靶点16,已经有研究表明68Ga-PSMA PET/CT在治疗前分期(一级分期)或复发检测(二级分期)中对疾病的出色诊断,不过到
Application of PSMA PET/CT and Bone Scan in the Diagnosis of Bone Metastases in Prostate Cancer 在线阅读 下载PDF 引用 收藏 分享 摘要 前列腺癌是男性中第二大常见癌症,2020年有191,930例新诊断病例和33,330例因前列腺癌死亡。前列腺癌(PCa)进展时常发生骨转移。大约70%的晚期前列腺癌患者发生骨转移。